世界主要国家(地区)细胞免疫政策分析

Cellular Immunotherapy Policies in Major Countries and Regions

发展迅速的细胞免疫治疗被认为是第4种治疗癌症的方法,临床应用前景广阔。鉴于细胞免疫技术的特殊性,其政策监管需要根据其独有的技术特点单独制定。本文首先分析了细胞免疫技术的发展现状,然后通过对世界主要国家与地区的细胞免疫政策监管的探讨,结合中国的实际情况,为中国细胞免疫的发展提出建议。

Cellular immunotherapy is considered to be the fourth method for treating cancer. Cellular immunotherapy technology is rapidly developing and possesses broad clinical applications. In view of the special nature, the regulatory policies of cellular immunotherapy technology need to be separately formulated according to its unique technical characteristics. Therefore, this paper firstly analyzes the development status of cellular immunotherapy technology. Then, based on the discussion about policies of cellular immunotherapy in major countries and regions in the world and China＇s actual conditions, suggestions are provided for the development of cellular immunotherapy in China.